• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素抵抗:代谢综合征的触发因素还是伴随因素?

Insulin resistance: trigger or concomitant factor in the metabolic syndrome.

作者信息

Avogaro A

机构信息

Unit of Metabolic Diseases, Department of Clinical and Experimental Medicine, University of Padua, Padua, Italy.

出版信息

Panminerva Med. 2006 Mar;48(1):3-12.

PMID:16633326
Abstract

The metabolic syndrome (MS) is a cluster of metabolic abnormalities with insulin resistance as a major characteristic. The main adverse consequence of the MS is cardiovascular disease (CVD). Complex, mutually reinforcing interactions between obesity and insulin resistance largely account for the pathogenesis of MS. Central pathophysiologic features include: insulin resistance, atherogenic dyslipidemia, chiefly present as low HDL-C together with increases in triglycerides and small dense, low density lipoprotein particles, hypertension, a proinflammatory state, with increases in acute-phase reactants, and a prothrombotic state. Although lifestyle and overeating seem to be the triggering pathogenic factors, genetic elements are also involved in the pathogenesis of MS. When present, insulin resistance results in impaired insulin action in insulin-sensitive tissues such as muscle, fat, and liver. Insulin resistance results in abnormalities of glucose metabolism, with reduced peripheral disposal of glucose in muscle and increased hepatic glucose output in the fasting state. But, most importantly, the progressively increasing concentration in circulating glucose leads to various abnormalities in insulin secretion. Elevated insulin levels themselves are atherogenic by inducing an oxidative stress and by stimulating sympathetic-nerve activity. Ectopic fat deposition, stress, proinflammatory state, and a maladaptive response of innate immunity may together concur to the development of the MS. When this condition is acknowledged, substantial modification of life style and correction of each single risk factor should be pursued without uncertainties and without hierarchical approach; this means that each risk factor should be treated and brought to target.

摘要

代谢综合征(MS)是一组以胰岛素抵抗为主要特征的代谢异常。MS的主要不良后果是心血管疾病(CVD)。肥胖与胰岛素抵抗之间复杂且相互强化的相互作用在很大程度上解释了MS的发病机制。主要的病理生理特征包括:胰岛素抵抗、致动脉粥样硬化性血脂异常,主要表现为高密度脂蛋白胆固醇(HDL-C)降低,同时甘油三酯升高以及小而密的低密度脂蛋白颗粒增加、高血压、促炎状态,表现为急性期反应物增加,以及血栓前状态。尽管生活方式和暴饮暴食似乎是触发致病因素,但遗传因素也参与了MS的发病机制。当存在胰岛素抵抗时,会导致胰岛素在肌肉、脂肪和肝脏等胰岛素敏感组织中的作用受损。胰岛素抵抗导致葡萄糖代谢异常,肌肉中葡萄糖的外周处置减少,空腹状态下肝脏葡萄糖输出增加。但最重要的是,循环葡萄糖浓度的逐渐升高会导致胰岛素分泌出现各种异常。胰岛素水平升高本身通过诱导氧化应激和刺激交感神经活动而具有致动脉粥样硬化作用。异位脂肪沉积、应激、促炎状态和先天免疫的适应性不良反应可能共同促成MS的发展。当认识到这种情况时,应毫无疑虑且不采取分级方法地对生活方式进行实质性改变并纠正每一个单一危险因素;这意味着应对每个危险因素进行治疗并使其达到目标。

相似文献

1
Insulin resistance: trigger or concomitant factor in the metabolic syndrome.胰岛素抵抗:代谢综合征的触发因素还是伴随因素?
Panminerva Med. 2006 Mar;48(1):3-12.
2
Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.胰岛素抵抗、血脂异常和腹内肥胖对心血管疾病和糖尿病发生发展的影响。
Am J Med. 2007 Mar;120(3 Suppl 1):S12-8. doi: 10.1016/j.amjmed.2007.01.003.
3
Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.胰岛素抵抗、胰岛素抵抗综合征与心血管疾病。
Panminerva Med. 2005 Dec;47(4):201-10.
4
The metabolic syndrome in women.女性代谢综合征
Cardiol Rev. 2006 Nov-Dec;14(6):286-91. doi: 10.1097/01.crd.0000233757.15181.67.
5
Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.腹部肥胖与代谢综合征:对全球心血管代谢风险的影响
Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1039-49. doi: 10.1161/ATVBAHA.107.159228. Epub 2008 Mar 20.
6
The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.胰岛素抵抗综合征:心血管风险聚集的机制
Semin Vasc Med. 2002 Feb;2(1):45-57. doi: 10.1055/s-2002-23095.
7
Hemostasis alterations in metabolic syndrome (review).代谢综合征中的止血改变(综述)
Int J Mol Med. 2006 Nov;18(5):969-74.
8
Metabolic syndrome.代谢综合征
Minerva Med. 2006 Jun;97(3):219-29.
9
Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk.腹部肥胖:在代谢性疾病病理生理学及心血管风险中的作用
Am J Med. 2007 Feb;120(2 Suppl 1):S3-8; discussion S29-32. doi: 10.1016/j.amjmed.2006.11.012.
10
Macrovascular complications of metabolic syndrome: an early intervention is imperative.代谢综合征的大血管并发症:早期干预势在必行。
Int J Cardiol. 2004 Nov;97(2):167-72. doi: 10.1016/j.ijcard.2003.07.033.

引用本文的文献

1
Saturated fats network identified using Gaussian graphical models is associated with metabolic syndrome in a sample of Iranian adults.使用高斯图形模型识别出的饱和脂肪网络与伊朗成年人样本中的代谢综合征有关。
Diabetol Metab Syndr. 2022 Aug 26;14(1):123. doi: 10.1186/s13098-022-00894-x.
2
The Epigenetic Role of MiRNAs in Endocrine Crosstalk Between the Cardiovascular System and Adipose Tissue: A Bidirectional View.微小RNA在心血管系统与脂肪组织内分泌串扰中的表观遗传作用:双向视角
Front Cell Dev Biol. 2022 Jul 4;10:910884. doi: 10.3389/fcell.2022.910884. eCollection 2022.
3
Association of dietary energy density with cardiometabolic risk factors and metabolic syndrome in Tehranian older adults.
德黑兰老年人膳食能量密度与心血管代谢危险因素及代谢综合征的关联
J Cardiovasc Thorac Res. 2020;12(2):97-105. doi: 10.34172/jcvtr.2020.17. Epub 2020 May 19.
4
Waist-hip ratio related genetic loci are associated with risk of impaired fasting glucose in Chinese children: a case control study.腰臀比相关基因位点与中国儿童空腹血糖受损风险相关:一项病例对照研究。
Nutr Metab (Lond). 2018 May 3;15:34. doi: 10.1186/s12986-018-0270-2. eCollection 2018.
5
New targets to treat obesity and the metabolic syndrome.治疗肥胖症和代谢综合征的新靶点。
Eur J Pharmacol. 2015 Sep 15;763(Pt A):64-74. doi: 10.1016/j.ejphar.2015.03.093. Epub 2015 May 19.
6
Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study.双苯丙戊嗪治疗精神分裂症急性加重期患者的疗效与安全性:一项随机、双盲、安慰剂对照、多中心、剂量探索性研究的结果
Psychopharmacology (Berl). 2008 Oct;200(3):317-31. doi: 10.1007/s00213-008-1207-7. Epub 2008 Jul 4.